Clover Health Investments, Corp. /De

Ownership Transactions Reported by 25 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	2	+1.44M	81.4%	$1.41	+$2.03M
Sells	3	-328K	18.6%	$3.66	-$1.2M
Net	-1	+1.11M	62.9%		+$828K

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Vivek Garipalli	Director, 10%+ Owner	$331M	+$2M	+0.61%	Jan 7, 2025
Andrew Toy	Chief Executive Officer, Director	$39.3M			Apr 1, 2025
Chamath Palihapitiya	FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner	$29.5M			Jul 7, 2021
Greenoaks Capital Partners Llc	Other*, 10%+ Owner	$24.5M			Nov 22, 2021
Conrad Wai	CEO, Counterpart Health	$11.9M			Mar 14, 2025
Jamie L. Reynoso	CEO, Medicare Advantage	$11.5M			Apr 3, 2025
Brady Priest	CEO of Home Care	$8.9M	-$276K	-3.01%	Apr 18, 2025
Peter Kuipers	Chief Financial Officer	$5.96M			May 8, 2024
Scott J. Leffler	Chief Financial Officer	$4.76M			Jan 25, 2024
Karen Soares	General Counsel & Secretary	$4.74M	-$200K	-4.04%	Mar 15, 2025
R. Aric Sharp	CEO of Value Based Care	$3.91M			Aug 9, 2024
Clover Health Investments, Corp. /De	Chief Technology Officer	$3.03M			Oct 31, 2023
Joseph R. Martin	General Counsel	$2.66M			Jun 14, 2023
Anna U. Loengard	Director	$2.07M	+$25.7K	+1.25%	Jan 6, 2025
Chelsea Clinton	Director	$1.98M			Jan 6, 2025
Lee Shapiro	Director	$1.97M			Jan 6, 2025
Demetrios L. Kouzoukas	Director	$1.73M			Jan 6, 2025
William G. Robinson Jr	Director	$1.71M			Jan 6, 2025
Nathaniel S. Turner	Director	$1.26M			Jan 7, 2021
Carladenise Edwards	Director	$986K	-$722K	-42.3%	Mar 7, 2025
Prabhdeep Singh	Chief Growth Officer	$855K			Sep 16, 2022
Thomas L. Tran	Director	$331K			Jan 6, 2025
Joseph Wagner	Chief Financial Officer	$24.5K			Aug 9, 2021
Terrence Ronan	Interim CFO				Jan 27, 2024
Mark Herbers	Interim CFO				Aug 13, 2021

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.